KalVista Pharmaceuticals, Inc.
KALV
$19.56
-$1.30-6.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 300.21M | 309.16M | 191.47M | 220.62M | 253.20M |
| Total Receivables | 11.30M | 7.12M | 6.50M | 15.14M | 9.40M |
| Inventory | 3.43M | 458.00K | -- | -- | -- |
| Prepaid Expenses | 5.20M | 8.49M | 7.93M | 5.93M | 4.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 320.15M | 325.23M | 205.90M | 241.69M | 267.36M |
|
|
|||||
| Total Current Assets | 320.15M | 325.23M | 205.90M | 241.69M | 267.36M |
| Net Property, Plant & Equipment | 12.86M | 12.29M | 7.23M | 7.53M | 7.25M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.37M | 2.42M | 2.38M | 1.55M | 1.39M |
| Total Assets | 335.38M | 339.93M | 215.51M | 250.77M | 275.99M |
|
|
|||||
| Total Accounts Payable | 8.27M | 8.07M | 5.87M | 4.88M | 5.86M |
| Total Accrued Expenses | 27.06M | 20.77M | 18.97M | 26.50M | 18.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.19M | 4.72M | 2.12M | 1.98M | 1.44M |
| Total Finance Division Other Current Liabilities | 6.84M | 11.51M | 11.41M | 11.81M | -- |
| Total Other Current Liabilities | 6.84M | 11.51M | 11.41M | 11.81M | -- |
| Total Current Liabilities | 57.36M | 45.07M | 38.38M | 45.17M | 25.62M |
|
|
|||||
| Total Current Liabilities | 57.36M | 45.07M | 38.38M | 45.17M | 25.62M |
| Long-Term Debt | 258.29M | 268.74M | 132.32M | 105.88M | 100.91M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.73M | 9.13M | 4.02M | 4.33M | 4.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.71M | -- | -- | -- | -- |
| Total Liabilities | 338.09M | 322.93M | 174.72M | 155.38M | 130.87M |
|
|
|||||
| Common Stock & APIC | 767.11M | 762.83M | 760.44M | 753.78M | 748.28M |
| Retained Earnings | -762.69M | -739.10M | -713.27M | -653.17M | -600.95M |
| Treasury Stock & Other | -7.13M | -6.73M | -6.39M | -5.21M | -2.21M |
| Total Common Equity | -2.71M | 17.00M | 40.79M | 95.39M | 145.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.71M | 17.00M | 40.79M | 95.39M | 145.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.71M | 17.00M | 40.79M | 95.39M | 145.13M |
|
|
|||||